---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-031638"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:23:20.514187+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BD Q2 FY2026 revenue $4.7B (+5.2% reported), GAAP EPS $(0.13), adj. EPS $2.90; raises FY adj. EPS guidance

## Summary
- Revenue $4,714M, +5.2% reported/2.6% FX-neutral; GAAP diluted EPS $(0.13) from continuing ops vs $0.55 prior year.
- Adjusted diluted EPS $2.90, up from $2.79 (+3.9% reported); company raises full-year adjusted EPS guidance.
- Executed $2.0B accelerated share repurchase and retired $2.1B of debt in the quarter.
- Reaffirms revenue growth guidance; more than 90% of business delivered mid-single-digit growth.
- Spin-off of Biosciences & Diagnostic Solutions completed Feb 9, 2026; results reflect continuing ops.

## SEC filing metadata
- accession: 0001628280-26-031638
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828026031638/0001628280-26-031638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828026031638/bdx-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-031638
- JSON: https://secwatch.observer/filing/0001628280-26-031638.json
- Plain text: https://secwatch.observer/filing/0001628280-26-031638.txt

## Source-grounded claims
- claim_id: 32b91f04523be5d7e69541a0ba992fb583539b32
  claim: BECTON DICKINSON & CO reported second fiscal quarter ending March 31, 2026 results: revenue $4,714, EPS $(0.13) and $2.90. Guidance raised.
  evidence_excerpt: Fiscal 2026 Operating Results Three Months Ended March 31, Reported Change Foreign Currency Neutral Change 1 (Millions of dollars, except per share amounts) 2026 2025 Revenues $ 4,714 $ 4,480 5.2 % 2.6 % Reported Diluted Earnings per Share $ (0.13) $ 0.55 (123.6) % (130.9) % Adjusted Diluted Earnings per Share 1 $ 2.90 $ 2.79 3.9 % 1.1 % 1 Represents a non-GAAP
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000162828026031638/0001628280-26-031638-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.